Chinese weight-loss drug ribupatide shows promise in trial
Summarised from 2 outlets · Updated 16 Nov, 09:49 · Archive
An experimental Chinese injection called ribupatide helped patients lose nearly a fifth of their body weight in 11 months.
An experimental Chinese weight-loss injection called ribupatide has produced significant weight loss in trial participants. In a study conducted by researchers at Fudan University in Shanghai involving 567 overweight or obese adults with an average age of 34, the once-weekly injection helped patients shed an average of 17.7 per cent of their body weight in 11 months.
Participants were divided into groups receiving different doses of the drug or a placebo. Those on the lowest dose lost an average of 10.7 per cent of their starting weight, those on the middle dose shed 16.4 per cent, and those on the highest dose lost 17.7 per cent. The placebo group lost just 1.4 per cent. Participants on the two highest doses were still losing weight when the study ended.
Ribupatide works by mimicking two hormones that help control appetite and blood sugar, helping people feel fuller for longer. This mechanism is similar to Mounjaro, which produces weight loss of around 22.5 per cent over 72 weeks. Wegovy, containing semaglutide, has been shown to help patients lose around 18.7 per cent of their weight over the same period. The drug is currently in phase three trials in Britain.

How it is being reported
- New Chinese jab could rival popular weight-loss drugs like Wegovy and MounjaroRibupatide is still being trialled in the UK, but some participants in a trial at Shanghai's Fudan University lost nearly a fifth of their body weight in 11 monthsThe Mirror · 16 Nov, 09:40
- New Chinese weight-loss jab could be more effective than Mounjaro - as users drop nearly a fifth of their body weight in under a yearIn a trial, the once-weekly injection ribupatide helped patients shed an average of 17.7 per cent of their body weight - almost a fifth - in just 11 months.Daily Mail · 15 Nov, 23:09
In this story: Ribupatide · Fudan University · Shanghai · Wegovy · Mounjaro
This summary was written by AI from the headlines and standfirsts above, and states as fact only what at least two outlets report. How we use AI · Report a problem · Corrections log
Comments (0)